WONDFO BIOTECH released its performance for the first three quarters, with a net profit attributable to the parent company of 134 million yuan, a decrease of 69.32%

According to the Zhitong Finance APP, WONDFO BIOTECH released its third-quarter report for 2025. The company's operating revenue for the first three quarters was 1.69 billion yuan, a year-on-year decrease of 22.52%. The net profit attributable to shareholders of the listed company was 134 million yuan, a year-on-year decrease of 69.32%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 82.6416 million yuan, a year-on-year decrease of 78.67%. The basic earnings per share were 0.28 yuan